Detailed Information

Cited 0 time in webofscience Cited 1 time in scopus
Metadata Downloads

Glucose-responsive artificial promoter-mediated insulin gene transfer improves glucose control in diabetic mice

Authors
Han, JaeseokKim, Eung-HwiChoi, WoohyukJun, Hee-Sook
Issue Date
28-Nov-2012
Publisher
BAISHIDENG PUBLISHING GROUP INC
Keywords
Insulin gene therapy; Synthetic promoter; Glucose-responsive element; Liver-specific promoter; Type 2 diabetes
Citation
WORLD JOURNAL OF GASTROENTEROLOGY, v.18, no.44, pp.6420 - 6426
Journal Title
WORLD JOURNAL OF GASTROENTEROLOGY
Volume
18
Number
44
Start Page
6420
End Page
6426
URI
https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/15992
DOI
10.3748/wjg.v18.i44.6420
ISSN
1007-9327
Abstract
AIM: To investigate the effect of insulin gene therapy using a glucose-responsive synthetic promoter in type 2 diabetic obese mice. METHODS: We employed a recently developed novel insulin gene therapy strategy using a synthetic promoter that regulates insulin gene expression in the liver in response to blood glucose level changes. We intravenously administered a recombinant adenovirus expressing furin-cleavable rat insulin under the control of the synthetic promoter (rAd-SP-rINSfur) into diabetic Lepr(db/db) mice. A recombinant adenovirus expressing beta-galactosidase under the cytomegalovirus promoter was used as a control (rAd-CMV-beta gal). Blood glucose levels and body weights were monitored for 50 d. Glucose and insulin tolerance tests were performed. Immunohistochemical staining was performed to investigate islet morphology and insulin content. RESULTS: Administration of rAd-SP-rINSfur lowered blood glucose levels and normoglycemia was maintained for 50 d, whereas the rAd-CMV-beta gal control virus-injected mice remained hyperglycemic. Glucose tolerance tests showed that rAd-SP-rINSfur-treated mice cleared exogenous glucose from the blood more efficiently than control virus-injected mice at 4 wk [area under the curve (AUC): 21 508.80 +/- 2248.18 vs 62 640.00 +/- 5014.28, P < 0.01] and at 6 wk (AUC: 29 956.60 +/- 1757.33 vs 60 016.60 +/- 3794.47, P < 0.01). In addition, insulin sensitivity was also significantly improved in mice treated with rAd-SP-rINSfur compared with rAd-CMV-beta gal-treated mice (AUC: 9150.17 +/- 1007.78 vs 11 994.20 +/- 474.40, P < 0.05). The islets from rAd-SP-rINSfur-injected mice appeared to be smaller and to contain a higher concentration of insulin than those from rAd-CMV-beta gal-injected mice. CONCLUSION: Based on these results, we suggest that insulin gene therapy might be one therapeutic option for remission of type 2 diabetes. (C) 2012 Baishideng. All rights reserved.
Files in This Item
There are no files associated with this item.
Appears in
Collections
약학대학 > 약학과 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Jun, Hee Sook photo

Jun, Hee Sook
Pharmacy (Dept.of Pharmacy)
Read more

Altmetrics

Total Views & Downloads

BROWSE